Renal transplantation for apolipoprotein AII amyloidosis

References

• Weiss S W, Page D L. Amyloid nephropathy of Ostertag with special reference to renal glomerular giant cells. Am J Pathol 1973; 72: 447–460
   PubMedGoogle Scholar
• Benson M D, Liepnieks J J, Yazaki M, Yamashita T, Hamidi Asl K, Guenther B, Kluve‐Beckerman B. A new human hereditary amyloidosis: the result of a stop‐codon mutation in the apolipoprotein AII gene. Genomics 2001; 72: 272–277
   PubMed Web of Science ®Google Scholar
• Yazaki M, Liepnieks J J, Yamashita T, Guenther B, Skinner M, Benson M D. Renal amyloidosis caused by a novel stop‐codon mutation in the apolipoprotein AII gene. Kidney Int 2001; 60: 1658–1665
   PubMed Web of Science ®Google Scholar
• Yazaki M, Liepnieks J J, Barats M S, Cohen A H, Benson M D. Hereditary systemic amyloidosis associated with a new apolipoprotein AII stop codon mutation Stop78Arg. Kidney Int 2003; 64: 11–15
   PubMed Web of Science ®Google Scholar
• Gillmore J D, Booth D R, Rela M, Heaton N D, Rahman V, Stangou A J, Pepys M B, Hawkins P N. Curative hepatorenal transplantation in systemic amyloidosis caused by the Glu526Val fibrinogen α‐chain variant in an English family. QJM 2000; 93: 269–275
   PubMed Web of Science ®Google Scholar
• Zeldenrust S, Gertz M, Uemichi T, Bjomsson J, Wiesner R, Schwab T, Benson M D. Orthotopic liver transplantation for hereditary fibrinogen amyloidosis. Transplantation 2003; 75: 560–561
   PubMed Web of Science ®Google Scholar
• Gillmore J D, Stangou A J, Tennent G A, Booth D R, O'Grady J, Rela M, Heaton N G, Wall C A, Keogh J A B, Hawkins P N. Clinical and biochemical outcome of hepatorenal transplantation for hereditary systemic amyloidosis associated with apolipoprotein AI Gly26Arg. Transplantation 2001; 71: 986–992
   PubMed Web of Science ®Google Scholar
• Yazaki M, Farrell S A, Benson M D. A novel lysozyme mutation Phe57Ile associated with hereditary renal amyloidosis. Kidney Int 2003; 63: 1652–1657
   PubMed Web of Science ®Google Scholar
• Gertz M A, Kyle R A. Prognostic value of urinary protein in primary systemic amyloidosis (AL). Am J CIin Pathol 1990; 94: 313–317
   PubMed Web of Science ®Google Scholar
• Gertz M A, Kyle R A, O'Fallon M. Dialysis support of patients with primary systemic amyloidosis. Arch Int Med 1992; 152: 2245–2250
   PubMedGoogle Scholar
• Hartmann A, Holdaas H, Fauchald P, Nordal K P, Berg K J, Talseth T, Leivestad T, Brekke I B, Flatmark A. Fifteen years experience with renal transplantation in systemic amyloidosis. Transpl Int 1992; 5: 15–18
   PubMedGoogle Scholar
• Jacob E T, Bar‐Nathan N, Gafni J. Improving outlook for renal transplantation in amyloid nephropathy. Tranplant Proc 1982; 14: 41
   Google Scholar
• Turkmen A, Yildiz A, Erkoc R, Ecder T, Gorcin B, Turk S, Aydin A E, Eldegez U, Ark E, Sever M S. Transplantation in renal amyloidosis. Clin Transplant 1998; 12: 375–378
   PubMed Web of Science ®Google Scholar
• Sever M S, Turkmen A, Sahin S, Yildiz A, Ecder T, Kayacan M S, Nane I, Aydin A E, Eldegez U. Renal tranplantation in amyloidosis secondary to Familial Mediterranean Fever. Transplant Proc 2001; 33: 3392–3393
   PubMed Web of Science ®Google Scholar
• Pastemak A, Ahonen J, Kuhlback B. Renal transplantation in 45 patients with amyloidosis. Transplantation 1986; 42: 598–601
   PubMedGoogle Scholar
• Isoniemi H, Eklund B, Hocherstedt K, Salmela K, Ahonen J. Renal transplantation in amyloidosis. Tranplant Proc 1989; 21: 2039–2040
   PubMedGoogle Scholar
• Sobh M, Refaie A, Moustafa F, Shokeir A, Hassan N, Sally S, Ghoneim M. Study of live donor kidney outcome in the recipients with renal amyloidosis. Nephro Dial Transplant 1994; 9: 704–708
   PubMedGoogle Scholar
• Karakayali H, Demirag A, Moray G, Ersoy E, Turan M, Bilgin N, Haberal M. Impact of amyloidosis on long‐term survival in kidney transplantation. Transplant Proc 1999; 31: 3221–3223
   PubMedGoogle Scholar
• Benson M D. Amyloidosis and other protein deposition diseases. Emery and Rimoin's Principles And Practice Of Medical GeneticsFourth Edition, D L Rimoin, R E Pyeritz, B R Korf. Churchill Livingstone, New‐York 2002; 2058–2073
   Google Scholar
• Van Allen M W, Frohlich J A, Davis J R. Inherited predisposition to generalized amyloidosis. Clinical and pathological study of a family with neuropathy, nephropathy, and peptic ulcer. Neurology 1969; 19: 10–25
   PubMed Web of Science ®Google Scholar
• Nichols W C, Gregg R E, Brewer H B, Benson M D. A mutation in apolipoprotein A‐I in the Iowa type of familial amyloidotic polyneuropathy. Genomics 1990; 8: 318–323
   PubMed Web of Science ®Google Scholar
• Hamidi Asl L, Liepnieks J J, Uemichi T, Rebibou J M, Justrabo E, Droz D, Mousson M, Chalopin J M, Benson M D, Delpech M, Grateau G. Renal amyloidosis with a frame shift mutation in fibrinogen A ‐chain gene producing a novel amyloid protein. Blood 1997; 90: 4799–4805
   PubMed Web of Science ®Google Scholar
• Pepys M B, Hawkins P N, Booth D R, Vigushin D M, Tennent G A, Soutar A K, Totty N, Nguyen O, Blake C C, Terry C J, Feest T G, Zalin A M, Hsuan J J. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 1993; 362: 553–557
   PubMed Web of Science ®Google Scholar
• Pomfret E A, Lewis W D, Jenkins R L, Bergethon P, Dubrey S W, Reisinger J, Falk R H, Skinner M. Effect of orthotopic liver transplantation on the progression of familial amyloid polyneuropathy. Transplantation 1998; 65: 918–925
   PubMed Web of Science ®Google Scholar
• Benson M D, Liepnieks J J, Uemichi T, Wheeler G, Correa R. Hereditary amyloidosis associated with a mutant fibrinogen α‐chain. Nat Genet 1993; 3: 252–255
   PubMed Web of Science ®Google Scholar
• Uemichi T, Liepnieks J J, Benson M D. Hereditary renal amyloidosis with a novel variant fibrinogen. J Clin Invest 1994; 93: 731–736
   PubMed Web of Science ®Google Scholar
• Uemichi T, Liepnieks J J, Alexander F, Benson M D. The molecular basis of renal amyloidosis in Irish‐American and Polish‐Canadian kindreds. QJM 1996; 89: 745–750
   PubMed Web of Science ®Google Scholar
• Valleix S, Drunat S, Philit J B, Adoue D, Piette J C, Droz D, MacGregor B, Canet D, Delpech M, Grateau G. Hereditary renal amyloidosis caused by a new variant lysozyme W64R in a French family. Kidney Int 2002; 61: 907–912
   PubMed Web of Science ®Google Scholar
• Costa R H, Lai E, Damell J E, Jr. Transcriptional control of the mouse prealbumin (transthyretin) gene: both promoter sequences and a distinct enhancer are cell specific. Mol Cell Biol 1986; 6: 4697–4708
   PubMedGoogle Scholar
• Rader D J, Gregg R E, Meng M S, Schaefer J R, Kindt M R, Zech L A, Benson M D, Brewer H B, Jr. In vivo metabolism of a mutant apolipoprotein, apoA‐IIowa, associated with hypoalpha‐lipoproteinemia and hereditary systemic amyloidosis. J Lipid Res 1992; 33: 755–763
   PubMed Web of Science ®Google Scholar